Simcere Pharmaceutical Group — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$2.4B

Net Income/Loss (FY2012)

-¥14.4M

Total Assets (FY2012)

¥541.4M

Total Equity (FY2012)

$3.2B

Cash Flows from Operating Activities (FY2012)

¥313.6M

Source: Simcere Pharmaceutical Group 20-F filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.